MSD

The headquarters of MERCK SHARP & DOHME (CHINA) LIMITED is located in Shanghai, reporting directly to the U.S. headquarters, with a total workforce of over 5,000 employees. In 2011, MSD invested $1.5 billion to establish a China R&D center in Beijing; in April 2013, MSD’s new plant in Hangzhou, which cost $120 million and covers an area of 75,000 square meters, officially began operations. It is one of the most advanced and largest pharmaceutical production and packaging facilities in China and the Asia-Pacific region. With this, MSD has achieved the integration of R&D, manufacturing, and commercial operations in China, better meeting the needs of Chinese patients and the general public. In addition to its prescription drug business, MSD's operations in China also include animal health products, offering nearly 50 veterinary products that cover disease prevention, treatment, and control in livestock, poultry, and pets, demonstrating a commitment to protecting and caring for animal health as well as human health that is closely intertwined with it.